©The Author(s) 2020.
World J Clin Cases. Nov 26, 2020; 8(22): 5564-5575
Published online Nov 26, 2020. doi: 10.12998/wjcc.v8.i22.5564
Published online Nov 26, 2020. doi: 10.12998/wjcc.v8.i22.5564
Table 5 Adverse reactions after treatment
| Adverse event | GEM + IRE group (n = 33) | GEM group (n = 35) | ||||
| Grade | I/II | III | IV | I/II | III | IV |
| Toxicity | ||||||
| Hypoalbuminemia | 5 | 0 | 0 | 3 | 0 | 0 |
| Lymphopenia | 2 | 0 | 0 | 1 | 0 | 0 |
| Hemoglobin reduction | 3 | 0 | 0 | 2 | 0 | 0 |
| Neutropenia | 1 | 0 | 0 | 0 | 0 | 0 |
| Thrombocytopenia | 2 | 0 | 0 | 3 | 0 | 0 |
| Vomiting | 2 | 0 | 0 | 3 | 0 | 0 |
| Hypokalemia | 1 | 0 | 0 | 1 | 0 | 0 |
| Diarrhea | 2 | 0 | 0 | 1 | 0 | 0 |
| Complications | ||||||
| Pancreatitis | 0 | 2 | 0 | 0 | 0 | 0 |
| Ascites | 2 | 0 | 0 | 4 | 0 | 0 |
| Bleeding from duodenal ulcer | 0 | 1 | 0 | 0 | 0 | 0 |
| Portal vein thrombosis | 1 | 0 | 0 | 3 | 0 | 0 |
| Loss of appetite | 2 | 0 | 1 | 0 | 0 | |
| Gastroparesis | 1 | 0 | 0 | 1 | 0 | 0 |
| Abdominal pain | 2 | 0 | 0 | 2 | 2 | 0 |
- Citation: Ma YY, Leng Y, Xing YL, Li HM, Chen JB, Niu LZ. Gemcitabine plus concurrent irreversible electroporation vs gemcitabine alone for locally advanced pancreatic cancer. World J Clin Cases 2020; 8(22): 5564-5575
- URL: https://www.wjgnet.com/2307-8960/full/v8/i22/5564.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i22.5564